Zach Lomis
About Zach Lomis
First-hand exposure to the key pain points plaguing our healthcare ecosystem spurred my insatiable desire to dramatically innovate the way we handle mental health and addiction treatment. Motivated with the hope to facilitate the next wave of clinical therapies, I work as an advisor, mentor, and partner to a multitude of startups, dedicating the rest of my career to forging a new frontier with the most progressive, innovative, and promising clinical research of our generation. What started with a personal journey transitioned to absolute passion to do everything in my power to facilitate what is far more than an investing trend, but a movement that is redefining the healthcare system we all know today - Centered on mental health as a whole and the opioid epidemic in specific. Help me revolutionize biopharma! Always happy to explore new ideas, initiatives, and unchartered territory, LET'S GO! Select Representative Investments: Amyris, Alto Neuroscience, GW Pharma, Cann, Roivant Sciences, Sensorium Therapeutics, Pure Beauty, Atai, Gilgamesh, Kanna Health, Radicle Science, Karuna Therapeutics, Concr, Delix Therapeutics, Pangea Botanica, Sage Therapeutics, Mesobis, Conception Bio, Heading Health, Clarity Technologies